Abstract Submission Guidelines

Submission Guidelines

  • Abstracts must be submitted through the dedicated Form
  • The site will stop accepting abstracts after 25th July 2026. Abstracts received via email will not be evaluated.
  • The presenting author must submit the abstract themselves
  • A presenting author may submit a maximum of 2 abstracts for consideration at form
  • The decision on abstract evaluation will be communicated to the presenting author via email by 31st July 2026.

Submission Category

  • All abstracts must be submitted in English, using Times New Roman, font size 12, and double spacing.
  • To ensure a blinded review, do not include identifying features such as the names of hospitals, medical colleges, clinics, or locations in the title or text of the abstract.
  • Do not include the names of authors or their affiliations in the body of the abstract. There will be a separate section to enter author details and affiliations on the submission platform.
  • The material in the abstract must be original and not previously published.
  • The title should be as brief as possible but clear enough to indicate the nature of the study. Abbreviations should not be used in the title, and the title should not be written entirely in capital letters.
  • The abstract is limited to 350 words (excluding title, authors, affiliations, etc.)

Structure your abstract using the following subheadings

Background

Aims & Objectives

Materials/Patients & Methods

Describe the selection of observations or experimental subjects in detail

Results

Present your results in a logical sequence.

Conclusions

Highlight new and important aspects of the study and the conclusions drawn from them.

Limitations

Conflict of Interest

A declaration of conflict of interest is mandatory.

No references, graphs, figures, or tables should be included. Please check spelling and grammar carefully. The abstract text will not be edited and will be reproduced exactly as submitted in the e-abstract book.

Submit Abstract